Australia markets closed

Retractable Technologies, Inc. (RVP)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
1.0600-0.0200 (-1.85%)
At close: 04:00PM EDT
1.0800 +0.02 (+1.89%)
After hours: 05:58PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.0800
Open1.0700
Bid1.0000 x 1100
Ask1.3000 x 1300
Day's range1.0599 - 1.0702
52-week range0.9500 - 1.7800
Volume45,346
Avg. volume76,569
Market cap31.733M
Beta (5Y monthly)2.10
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Retractable Technologies, Inc. Reports Results for 2023

    LITTLE ELM, Texas, March 29, 2024--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2023. Further details concerning the results of operations as well as other matters are available in Retractable’s Form 10-K filed on March 29, 2024 with the U.S. Securities and Exchange Commission.

  • Business Wire

    Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

    LITTLE ELM, Texas, March 29, 2024--Retractable Technologies, Inc. ("Retractable") (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2024 through March 31, 2024. The dividends will be paid on April 22, 2024 to sh

  • Business Wire

    Retractable Technologies, Inc. Not Impacted by FDA Safety Communication

    LITTLE ELM, Texas, December 01, 2023--Retractable Technologies, Inc. (NYSE American: RVP) reports that the FDA Safety Communication "Evaluating Plastic Syringes Made in China for Potential Device Failures" on November 30, 2023 does not refer to syringes from Retractable Technologies Inc. The FDA identified quality issues related to "leaks, breakage, and other problems after manufacturers made changes to the syringe dimensions." Retractable Technologies has not incorporated any recent changes to